GFAP and periventricular leukomalacia: Funding The project (number 20200051) received funding under the Tertiary development and research work of University Medical Centre Ljubljana from: 1/1/2020 to 31/12/2022, entitled “Predictive value of glial fibrillary acidic protein (GFAP) for the development of periventricular leukomalacia and intraventricular hemorrhage in premature newborns”.